Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,477 total articles
Brookfield Asset Management ($BAM) looks positioned to accelerate buybacks as record capital formation and large energy & storage transactions increase fee-bearing AUM and free cash flow. At $53.27 the stock offers a tactical long with defined risk: entry $53.25, stop $50.00, target $62.00 over a 180 trading-day horizon.
Credo Technology is benefiting from explosive AI-driven demand for high-speed connectivity. With fiscal 2026 revenue above $1.3B, strong free cash flow and large insider stakes, Credo is a high-conviction growth trade. This plan outlines an entry at $246.38, a $320 target over 180 trading days, and a protective $225 stop to capture further multiple…
OHB SE (OHBTF) is a European space and defense systems company trading OTC with limited liquidity. Rising European defense budgets and renewed focus on sovereign space capabilities create a clear demand pathway for OHB's products and systems. Given the stock's previous close at $294.75 and a marked decline in headline short interest since mid-2026,…
Brookfield Asset Management is executing a credible turnaround centered on energy transition assets and corporate simplification. With a $7 billion Aypa Power buy, a major clean-power tie-up with Bloom Energy, solid free cash flow, and a 3.7% dividend yield, Brookfield has the pieces to re-accelerate earnings and fee growth. I'm initiating a long p…
Costco (COST) looks expensive on headline multiples but its cash flow, low leverage and durable membership model make a high-conviction trade. Entry near $949, stop at $900, target $1,095; plan for a position-sized trade over the next 180 trading days while monitoring margin and membership signals.
Games Workshop's new Amazon distribution angle is a clear accelerator for reach and seasonality, but it is not the fundamental investment case. The long trade outlined here treats Amazon as a catalyst that de-risks near-term top-line momentum while maintaining strict risk controls for valuation and execution risk.
Palantir just ripped higher after blowout Q2 results and a high-profile Nvidia partnership. The company’s execution and sovereign-AI positioning argue for more upside, but valuation and short-term technicals look stretched. Trade idea: enter at $175.00, stop at $162.00, target $205.00 over a mid-term (45 trading days) horizon.
BILL Holdings (BILL) has the profile of a turnaround that still has momentum: steady core revenue growth, healthy free cash flow, and a valuation that looks reasonable against its cash generation. This trade idea lays out an actionable mid-term swing with precise entry, stop and target levels tied to technical and fundamental triggers.
Ciena is benefiting directly from hyperscaler spending on dense optical infrastructure to feed AI clusters. With a $7.7B backlog, accelerating revenue growth, and strong free cash flow, the stock offers a tactical long entry amid market weakness. The trade balances a clear growth narrative against stretched multiples and recent convertible-note act…
Lionsgate has started the year with visible operational momentum tied to content and licensing, but corporate strategy questions could make the company difficult to own through year-end. I’m proposing a mid-term long trade that captures near-term re-rating while protecting against late-cycle downside tied to M&A or refinancing outcomes.
Lululemon is positioned to accelerate revenue and margin expansion via international rollouts and continued category extension. Recent execution improvements and a valuation that looks conservative versus the company 92s growth profile create an asymmetric risk/reward. We lay out an actionable long trade with entry, stop and target and a clear hori…
B2Gold (BTG) looks poised for a step-change in reported cash flow as the Fekola Regional package secures permits and prepayment obligations wind down. With 2025 production near 980k oz and $3.0B in revenue, the company has the scale to convert higher operating cash flow into balance-sheet optionality and shareholder returns. We lay out an actionabl…
Micron (MU) has corrected roughly 30% from its 52-week peak yet still shows strong fundamentals: $1.05T market cap, trailing EPS of $44.69 and roughly $26.2B in free cash flow. Technicals are neutral-to-constructive and the AI-driven HBM cycle gives a path back to prior highs. This trade targets $1,250 with a $780 stop, sized for a long-term recove…
HII sits at the center of a multi-year spending wave in nuclear submarines and carriers. Recent contract awards, upgraded guidance and government initiatives point to steady revenue and margin expansion that the market has only partially priced. This trade lays out an entry, stop, targets and the rationale for a long-term trade that captures backlo…
ALSMY has been range-bound and sentiment-challenged after a profit/guidance hiccup, but recent contract wins and confirmed FY guidance coupled with improving technicals create an asymmetric risk-reward. This trade idea outlines an entry at $1.82, a stop at $1.56 and a $2.60 target over a position-term horizon.
I added to my MACOM (MTSI) position on the pullback below $310. The business is increasingly exposed to AI-driven data-center optical demand, recently reported double-digit revenue growth, and has taken steps to shore up supply chain risk. Technically, price sits near its 50-day EMA providing a concise entry with defined downside. This is a mid-ter…
Veracyte (VCYT) runs a diversified diagnostics portfolio (Afirma, Percepta, Envisia) that is producing positive free cash flow and a tidy balance sheet. Valuation looks reasonable against cash generation; technicals are soft, presenting a tactical entry opportunity. This trade idea lays out an entry at $47.50 with a $60.00 target and a $42.00 stop …
Gilead Sciences looks cheap to cash-flow, not to headline multiples. With $12.9B in free cash flow, a durable HIV/viral franchise, and multiple near-term clinical and commercial catalysts, the market appears to be underpricing growth potential. I upgrade GILD to a constructive long and lay out an actionable trade plan with entry, stop and targets a…
Greg Abel has started to deploy Berkshire's record cash balance aggressively: Q2 saw the largest buyback in five years, a $6.8B acquisition of Taylor Morrison and a meaningful bump into Alphabet. At roughly $780k per Class A share, Berkshire trades at a reasonable P/E and still generates meaningful free cash flow. This trade targets a mid-term pop …
Verizon combines a strong cash flow profile, an above-market dividend yield, and fresh revenue upside from large dark-fiber and AI infrastructure deals. Valuation is reasonable by telecom standards and technicals support additional upside. This trade idea outlines an actionable long position with entry, stop and target, a clear time horizon, and a …
Aspen Aerogels designs advanced aerogel insulation used in energy infrastructure and is pushing into EV thermal management. The shares trade like a sub-$1B materials small cap with improving technicals and clear end-market tailwinds from EVs and decarbonization. This trade aims to capture re-rating as commercialization milestones and volume ramp ev…
Palantir just reported blowout growth and now sits on a multi-billion dollar contract backlog. The market is finally responding; momentum is strong, but the stock is richly priced. This trade idea offers a defined long with a 180-trading-day horizon, explicit entry, stop and target, and a balanced look at catalysts and risks.
Flywire (FLYW) has seen its margins compress as the business reinvests in growth and integration projects. The market is treating that as a structural problem; we see a temporary hit to margins against durable revenue growth, solid free cash flow ($159.2M trailing), and a reasonable valuation (P/S ~3.0). This trade targets a rebound as operating le…
Blue Owl has been punished with headline risk and heavy short interest, but its underlying economics - $1.32B in free cash flow, a $19B market cap, and a dividend supported by recurring fee income - argue for a constructive trade. This is a tactical long: enter near current levels, protect with a defined stop, and target meaningful upside as flows …
Assured Guaranty (AGO) has tumbled into oversold territory after a heavy session that left the shares near the 52-week low. Fundamentals remain intact: ~$3.3B market cap, P/E below 10, price-to-book around 0.6 and a modest quarterly dividend. This trade targets a mean-reversion recovery toward $85 while keeping a tight stop under recent support.
